DE282711C - - Google Patents

Info

Publication number
DE282711C
DE282711C DENDAT282711D DE282711DA DE282711C DE 282711 C DE282711 C DE 282711C DE NDAT282711 D DENDAT282711 D DE NDAT282711D DE 282711D A DE282711D A DE 282711DA DE 282711 C DE282711 C DE 282711C
Authority
DE
Germany
Prior art keywords
anthracene
solution
yellow
acid
aceanthrenequinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT282711D
Other languages
German (de)
English (en)
Publication of DE282711C publication Critical patent/DE282711C/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/62Cyclic imides or amidines of peri-dicarboxylic acids of the anthracene, benzanthrene, or perylene series

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
DENDAT282711D Active DE282711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Publications (1)

Publication Number Publication Date
DE282711C true DE282711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family

ID=538341

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT282711D Active DE282711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Country Status (1)

Country Link
DE (1) DE282711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Similar Documents

Publication Publication Date Title
DE282711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE484360C (de) Verfahren zur Darstellung von organischen Rhodanverbindungen
DE3022783C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE923690C (de) Verfahren zur Herstellung metallhaltiger Phthalocyanine
DE906935C (de) Verfahren zur Herstellung von Isolierung von Zwischenprodukten der Phthalocyaninsynthese
DE360530C (de) Verfahren zur Einfuehrung von Arylaminogruppen in Aminoanthrachinone
DE269842C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE238981C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE259145C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE535148C (de) Verfahren zur Darstellung von Oxazinverbindungen
DE287756C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE280092C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE250154C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE97639C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE426347C (de) Verfahren zur Herstellung von Aminobenzanthronderivaten
DE430631C (de) Verfahren zur Darstellung von Beizenfarbstoffen der Phenanthrenchinonreihe
DE290983C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE128955C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2846432C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE234917C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE445390C (de) Verfahren zur Herstellung von Dinaphthyldicarbonsaeuren
AT256850B (de) Verfahren zur Herstellung von neuen 3H-Pyrimido-[5,4-c]-1,2,5-oxadiazinderivaten
DE496393C (de) Verfahren zur Darstellung von Anthrachinon und seinen Abkoemmlingen
DE810052C (de) Verfahren zur Herstellung von Leukoschwefelsaeureestern verkuepbarer Verbindungen der Anthrachinon- und Indigoreihe
DE362984C (de) Verfahren zur Darstellung von Derivaten des 1,1-Dianthrachinonyls